Lee Kyung-Yil
Department of Pediatrics, The Catholic University of Korea, Daejeon St Mary's Hospital, 520-2 Daeheung 2-dong, Jung-gu, Daejeon 301-723, Republic of Korea.
Expert Rev Anti Infect Ther. 2008 Aug;6(4):509-21. doi: 10.1586/14787210.6.4.509.
Mycoplasma pneumoniae is one of the most common agents of community-acquired pneumonia in children and young adults. Although M. pneumoniae is a small bacterium that can reproduce in an artificial culture medium and is known to be sensitive to certain antibiotics in vitro as well as in vivo, the immunopathogenesis of M. pneumoniae in the human host is not fully understood. The epidemiologic characteristics, including periodic epidemics, and some clinical characteristics of M. pneumoniae are similar to those observed in systemic viral infections. Many experimental and clinical studies have suggested that the pathogenesis of lung injuries in M. pneumoniae infection is associated with a cell-mediated immune reaction, including high responsiveness to corticosteroid therapy. This paper presents an overview of M. pneumoniae infections, with emphasis on epidemiology, pathogenesis and treatment.
肺炎支原体是儿童和年轻人社区获得性肺炎最常见的病原体之一。虽然肺炎支原体是一种能够在人工培养基中繁殖的小细菌,并且已知在体外和体内对某些抗生素敏感,但肺炎支原体在人类宿主中的免疫发病机制尚未完全了解。肺炎支原体的流行病学特征,包括周期性流行,以及一些临床特征与全身性病毒感染中观察到的相似。许多实验和临床研究表明,肺炎支原体感染引起肺损伤的发病机制与细胞介导的免疫反应有关,包括对皮质类固醇治疗的高反应性。本文概述了肺炎支原体感染,重点介绍了流行病学、发病机制和治疗。